URL has been copied successfully!
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- RBC Capital raised the price target for Chemours Co (NYSE:CC) from $26 to $29. RBC Capital analyst Arun Viswanathan maintained an Outperform rating. Chemours shares traded at $24.64 on Monday. See how other analysts view this stock.
- DA Davidson lowered MSA Safety Inc (NYSE:MSA) price target from $235 to $206. DA Davidson analyst Michael Shlisky maintained a Buy rating. MSA Safety shares traded at $170.34 on Monday. See how other analysts view this stock.
- Oppenheimer cut price target for Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) from $87 to $84. Oppenheimer analyst Leland Gershell maintained an Outperform rating. Crinetics Pharmaceuticals shares traded at $36.77 on Monday. See how other analysts view this stock.
- Macquarie raised the price target for IREN …
Please follow us:
This post was originally published here
